UC BMT Program
3130 Highland Avenue
Cincinnati, OH 45219
Direct phone: (513) 584-4268
Total transplants by cell source
- Marrow: 1
- PBSC: 15
- Cord Blood: 0
- Autologous (PBSC or Marrow): 26
About the center
The University of Cincinnati Transplant and Cellular Therapy Program, led by Edward Faber, MD, is one of few transplantation sites which offers treatment in one outpatient hospital setting. Designed with patient comfort and convenience in mind, the center features state-of-the-art cellular therapy infusion suites and exam rooms along with integrative appointment scheduling. Patients can expect a care team consisting of hematology oncology specialists who focus exclusively on blood cancers as well as dedicated radiation oncologists, cancer and bone marrow transplant-trained hospitalists, pathologists, oncology nurse practitioners and nurses, pharmacists, dietitians, oncology social workers, a nurse educator for patients and caregivers and a director for clinical quality management.
This center has been performing allogeneic transplants since 2013 and has been an NMDP/Be The Match transplant center since August 2018.
Adult - John Byrd, Emily Curran, Edward Faber, Bryan Hambley, Tahir Latif, Pier Paolo Scaglioni
Cord blood transplants performed on
Other programs and services
Lodging: Our hospital has established preferred relationships with the hotels below, which are convenient to our facilities across the Greater Cincinnati Area. We also have established a preferred relationship with Executive Transportation for shuttle service, should it be required.
Preferred Accommodations include:
Cincinnati Marriott North, Residence Inn Cincinnati Downtown, Cincinnati Marriott Northeast, and Holiday Inn Cincinnati Airport. Please refer to the following link for more information:
Support service (Interpreter, Volunteer Services, Pets, Social services etc.)
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2018, 2019, 2020, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 18 patients.
The actual 1-year survival of these patients is 83.3%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 55.3% and 93.0%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2020 to December 31st, 2021 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2020 to December 31st, 2021 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
Transplant center coordinator:
Mary Beth Shirley
If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)